Genescient Receives Additional Angel Funding
December 17, 2009 by admin
Irvine, CA, December 17, 2009 — Genescient Corporation, a California genomic-health biotechnology company, received $500,000 in new angel investment, to help commercialize the company’s technology and to fund further research.
The investment was made by private investors with an interest in the rapidly growing field of nutrigenomics, based on the science of epigenetics and its promise of healthy life extension. A spokesman for the investors, Douglas Arends, stated: “We are especially interested in the genomics work Genescient has completed to identify human genes of aging. This...
Read Full Article »
Genescient Chairman to Speak at Singularity Summit 2009
August 24, 2009 by admin
Irvine, CA, August 24, 2009 — Gregory Benford, Chairman of the Board of Genescient Corporation, will speak at the Singularity Summit 09. The Singularity Summit is a gathering of visionaries in business, science, technology, design, and the arts, coming together to explore the rising impact of science and technology on society. This year’s Summit will take place on October 3 and 4 in Manhattan, and marks the first time that the Singularity Summit will be held on the East coast.
Benford will present on Genescient’s revolutionary approach to extended human longevity, with contiguous...
Read Full Article »
Caffeine Cuts Male Mating Success
August 19, 2009 by admin
Genescient study suggests that, when long-term effects are considered, two commonly ingested stimulants are not created equal. The study compares the effects of two stimulants and two sedatives.
Irvine, CA, August 19, 2009 – What long-term effect does your daily cup of “morning Joe” have on your body? In a study just published in PLoS One scientists at Genescient Corporation, a California biotechnology company, sought to answer that question. The study evaluated the long-term health effects of two stimulants — coffee and chocolate — and two sedatives — valproic...
Read Full Article »
Genescient and Kronos Announce Alzheimer’s Disease Collaboration
March 4, 2009 by admin
Genescient Corporation and Kronos Science Laboratory will work together to analyze the Kronos Alzheimer’s Case-Control Database, considered to be the finest Alzheimer’s Disease genetic data set in the US. The companies hope to identify genes previously unrecognized genes that are involved in Alzheimer’s Disease.
PET scan of a human brain with Alzheimer's disease / NIA
Irvine, CA, March 04, 2009 — Genescient Corporation (“Genescient”) and Kronos Science Laboratory, Inc. (“Kronos”) have entered into a collaborative agreement. Genescient will use its proprietary...
Read Full Article »